| Blood Cancer Discovery |
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia |
Publication |
2022 |
| Cancer Research |
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer |
Publication |
2022 |
| American Pancreatic Association |
SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes |
Abstract |
2023 |
| Journal for ImmunoTherapy of Cancer |
Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non- small cell lung cancer |
Publication |
2023 |
| medRxiv |
Pilot study demonstrating changes in DNA hydroxymethylation enable detection of multiple cancers in plasma cell-free DNA |
Publication |
2020 |
| American Diabetes Association 83rd Scientific Sessions |
Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting |
Abstract |
2023 |
| American Association for Cancer Research |
Evaluation of the Avantect Pancreatic Cancer Test for Identifying High-Risk Pancreatic Cysts |
Abstract |
2023 |
| Clinical Gastroenterology and Hepatology |
Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA |
Publication |
2023 |
| American Society of Clinical Oncology, Gastrointestinal Cancers |
Early detection of pancreatic cancer using 5-hydroxymethylation profiles in plasma-derived cell-free DNA |
Abstract |
2023 |
| Digestive Disease Week |
Detection of High-Risk Pancreatic Cysts Using Avantect™ Blood-Based Test |
Abstract |
2024 |
